Albany Molecular Research, Inc. has changed its brand name and is now conducting its business throughout the world as AMRI. This rebranding “reflects the company’s 16-year evolution into a global contract services and R&D organization,” according to a company statement. AMRI provides a broad range of scientific services, products and technologies to the life sciences industry, encompassing all of the company’s subsidiaries, including operations in the U.S., Europe and Asia.

“This rebranding of Albany Molecular Research, Inc. to AMRI reflects the company’s evolution from a small regional operation to a much larger business on a global scale,” said AMRI chairman, president and chief executive officer, Thomas E. D’Ambra, Ph.D. “The new brand allows us to connect to our past to retain and build on our commitment to customer satisfaction and loyalty; at the same time creating a modern and dynamic global identity as we continue our transition into a larger company. Additionally, it is an opportunity for us to reinforce a common mission and purpose across all of our locations and technologies, versus the multiple and sometimes confusing identities of several different site names.”

While the legal name of the company will not be affected by the rebranding, the name of Organichem Corp.—a wholly owned subsidiary of AMRI located in Rensselaer, NY—has been legally changed to AMRI Rensselaer, Inc., and will be included under the AMRI brand.